Amoxicillin/Vonoprazan Fumarate

阿莫西林/富马酸伏诺拉生

Report date: 2023/12/27 20:05:21

Base Information

Drug NameAmoxicillin/Vonoprazan Fumarate
Drug Alias NameVOQUEZNA DUAL PAK
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionBacterial penicillin-binding protein inhibitorsPotassium-transporting ATPase inhibitors
TargetsBacterial penicillin-binding proteinPotassium-transporting ATPase
Therapy Area/IndicationsHelicobacter pylori infection
Global Approved IndicationsHelicobacter pylori infection
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved Date2022/05/03
Country/TerritoryUnited States
CombinationsYes AmoxicillinVonoprazan Fumarate
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesPhathom Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesPhathom Pharmaceuticals Inc
Inactive CompaniesN/A
Active IndicationsHelicobacter pylori infection
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A